Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2020 Nov 13;295(46):15794. doi: 10.1074/jbc.AAC120.016409

Correction: Intermittent enzyme replacement therapy prevents Neu1 deficiency

Amanda R Luu, Cara Wong, Vishal Agrawal, Nathan Wise, Britta Handyside, Melanie J Lo, Glenn Pacheco, Jessica B Felix, Alexander Giaramita, Alessandra d'Azzo, Jon Vincelette, Sherry Bullens, Stuart Bunting, Terri M Christianson, Charles M Hague, Jonathan H LeBowitz, Gouri Yogalingam
PMCID: PMC7667986  PMID: 33188082

VOLUME 295 (2020) PAGES 13556–13569

The title of this article was inadvertently swapped with the running title. This error has now been corrected, and the title should read: “Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.”


Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES